Vertex Pharmaceuticals Inc. buy SVB Leerink LLC
Start price
29.12.25
/
50%
€393.15
Target price
29.12.26
€445.67
Performance (%)
-1.82%
Price
01.04.26
€386.00
Summary
This prediction is currently active. With a performance of -1.82%, the BUY prediction for Vertex Pharmaceuticals Inc. by SVB_Leerink_LLC is down slightly. This prediction currently runs until 29.12.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.088% | -1.088% |
| iShares Core DAX® | 0,75 % | -8,50 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % |
| iShares S&P 500 | -0,59 % | -2,87 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) had its price target raised by analysts at Leerink Partners from $456.00 to $525.00. They now have an "outperform" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€330.00
25.09.25
25.09.25
€388.33
25.09.26
25.09.26
16.97%
01.04.26
01.04.26
